cerliponase alfa

Spain

Drugs containing this active substance

  • BRINEURA 150 MG SOLUTION FOR INFUSION

    It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (NCL2), also known as tripeptidyl-peptidase 1 (TPP1) deficiency. It helps reduce the accumulation of materials in the body, especially in the brain, to delay the progression of the disease.

    Form: solution for infusion

    Active substance Dosage
    cerliponase alfa 150 mg/ml

    ATC: A16A A16AB A16AB17

    Manufacturer: Biomarin International Limited